| name: | Rimiterol | |
| ATC code: | R03AC05 | route: | inhalation | 
| compartments: | 1 | |
| dosage: | 200 | mg | 
| volume of distribution: | 2.5 | L | 
| clearance: | 300 | mL/min | 
| other parameters in model implementation | ||
Rimiterol is a short-acting beta-2 adrenergic receptor agonist previously used as a bronchodilator in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It is not widely used or approved in current clinical practice, having largely been replaced by other beta-2 agonists such as salbutamol.
Pharmacokinetic parameters were not identified in published literature for any population. Reported values are plausible estimates based on similarity to other short-acting beta-2 agonists orally inhaled, such as salbutamol, and available secondary sources.